tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRVO Stock Latest News

CervoMed price target lowered to $16 from $20 at Roth Capital
The FlyCervoMed price target lowered to $16 from $20 at Roth Capital
3d ago
CRVO
CervoMed Reports Promising Trial Results and Financial Update
PremiumCompany Announcements
CervoMed Reports Promising Trial Results and Financial Update
4d ago
CRVO
CervoMed reports Q2 EPS (70c), consensus (50c)
PremiumThe Fly
CervoMed reports Q2 EPS (70c), consensus (50c)
4d ago
CRVO
CervoMed expects cash to fund operations into Q3 of 2026
PremiumThe Fly
CervoMed expects cash to fund operations into Q3 of 2026
4d ago
CRVO
CervoMed Shares Business and Financial Updates Online
PremiumCompany Announcements
CervoMed Shares Business and Financial Updates Online
10d ago
8K
CRVO
CervoMed price target raised to $27 from $21 at Canaccord
PremiumThe FlyCervoMed price target raised to $27 from $21 at Canaccord
17d ago
CRVO
CervoMed’s Promising Clinical Trial Data and Strategic Focus Boost Buy Rating and Price Target
Premium
Ratings
CervoMed’s Promising Clinical Trial Data and Strategic Focus Boost Buy Rating and Price Target
18d ago
CRVO
CervoMed Announces Positive Phase 2b Trial Results
Premium
Company Announcements
CervoMed Announces Positive Phase 2b Trial Results
18d ago
8K
CRVO
CervoMed announces 32-week data from Extension phase of Phase 2b RewinD-LB
PremiumThe Fly
CervoMed announces 32-week data from Extension phase of Phase 2b RewinD-LB
18d ago
CRVO
CervoMed Stockholders Approve Key Proposals at Annual Meeting
PremiumCompany Announcements
CervoMed Stockholders Approve Key Proposals at Annual Meeting
2M ago
8K
CRVO
CervoMed appoints Marco Verwijs as EVP, technical operations
PremiumThe Fly
CervoMed appoints Marco Verwijs as EVP, technical operations
2M ago
CRVO
CervoMed Releases New Business and Financial Information
PremiumCompany Announcements
CervoMed Releases New Business and Financial Information
3M ago
8K
CRVO
CervoMed’s Strategic Advancements and Market Opportunities Drive Buy Rating
PremiumRatingsCervoMed’s Strategic Advancements and Market Opportunities Drive Buy Rating
3M ago
CRVO
CervoMed’s Promising Future: Buy Rating Backed by Strong Pipeline and Financial Position
Premium
Ratings
CervoMed’s Promising Future: Buy Rating Backed by Strong Pipeline and Financial Position
3M ago
CRVO
CervoMed Inc. Reports Q1 2025 Financial Results
Premium
Company Announcements
CervoMed Inc. Reports Q1 2025 Financial Results
3M ago
CRVO
CervoMed Announces $50M Sales Agreement with Leerink
PremiumCompany Announcements
CervoMed Announces $50M Sales Agreement with Leerink
3M ago
8K
CRVO
CervoMed reports Q1 EPS (56c), consensus (62c)
PremiumThe Fly
CervoMed reports Q1 EPS (56c), consensus (62c)
3M ago
CRVO
CervoMed sees cash runway into mid-2026
PremiumThe Fly
CervoMed sees cash runway into mid-2026
3M ago
CRVO
CervoMed participates in a meeting with Roth MKM
PremiumThe Fly
CervoMed participates in a meeting with Roth MKM
4M ago
CRVO
CervoMed Announces Executive Appointments and Changes
PremiumCompany AnnouncementsCervoMed Announces Executive Appointments and Changes
4M ago
8K
CRVO
CervoMed’s Promising Data and Phase 3 Prospects Boost Buy Rating
Premium
Ratings
CervoMed’s Promising Data and Phase 3 Prospects Boost Buy Rating
4M ago
CRVO
CervoMed Reports Positive Phase 2b Trial Results
Premium
Company Announcements
CervoMed Reports Positive Phase 2b Trial Results
4M ago
8K
CRVO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >